P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE

Detalles Bibliográficos
Autores principales: D’agostino, Mattia, Bringhen, Sara, Giuliani, Nicola, Antonioli, Elisabetta, Zambello, Renato, Cattel, Francesco, Ria, Roberto, Allegra, Alessandro, Leonardi, Giovanna, Belotti, Angelo, Galieni, Piero, Margiotta-Casaluci, Gloria, Cantonetti, Maria, Cotugno, Valentina, Gamberi, Barbara, Pane, Fabrizio, Liberati, Anna Marina, Tosi, Patrizia, Cavalli, Maide Maria, Mannina, Donato, Benevolo, Giulia, Mangiacavalli, Silvia, Evangelista, Andrea, Ciccone, Giovannino, Boccadoro, Mario, Bruno, Benedetto, Larocca, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430276/
http://dx.doi.org/10.1097/01.HS9.0000973592.99386.9a
Descripción
Sumario:

Ejemplares similares